Evaluation of the Consequences of Poly Vaccination on Innate Immunity : Applications to a Military Population
NCT06110741 · Status: NOT_YET_RECRUITING · Type: OBSERVATIONAL · Enrollment: 410
Last updated 2023-11-01
Summary
In this study, the poly vaccination of military personnel prior to deployment will be analyzed in terms of central, peripheral and long-lasting changes in innate immunity.
Analysis of monocyte immune training induced by vaccination will provide a better understanding of the indirect effects of vaccination and their persistence over time.
Conditions
- Vaccine Breakthrough Infections
Interventions
- OTHER
-
Blood and saliva sampling
Collecting blood and saliva sample
- OTHER
-
Survey
Collecting data on infectious diseases during the study period
Sponsors & Collaborators
-
Direction Centrale du Service de Santé des Armées
lead OTHER
Eligibility
- Min Age
- 18 Years
- Max Age
- 60 Years
- Sex
- ALL
- Healthy Volunteers
- Yes
Timeline & Regulatory
- Start
- 2023-11-30
- Primary Completion
- 2026-04-30
- Completion
- 2026-04-30
More Related Trials
-
Efficacy, Safety, and Immunogenicity of Two Vaccination Schedules of an Inactivated Vaccine Against COVID-19 in Adults
NCT04651790 ·Status: COMPLETED ·Phase: PHASE3
-
Immune Response to PNEUMOVAX 23 in Healthy Adults Receiving Efgartigimod IV
NCT05163834 ·Status: COMPLETED ·Phase: PHASE1
-
Efficacy of Different COVID-19 Vaccine Combinations in Inducing Long-term Humoral Immunity [PRIBIVAC]
NCT05142319 ·Status: COMPLETED ·Phase: PHASE4
-
Humoral Determinants of Immunity to Pneumococcal Infection
NCT00304382 ·Status: COMPLETED ·Phase: PHASE4
-
Study Evaluating the Impact of a 13-valent Pneumococcal Conjugate Vaccine on Nasopharyngeal Colonization
NCT00508742 ·Status: COMPLETED ·Phase: PHASE3
-
Trial to Evaluate the Safety and Immunogenicity of a Multivalent Pneumococcal Conjugate Vaccine in Adults 60 Through 64 Years of Age
NCT03313037 ·Status: COMPLETED ·Phase: PHASE2
-
National, Non Interventional Study of Invasive Pneumococcal Disease in Children and Newborns
NCT04664556 ·Status: RECRUITING
-
Evaluation of the Immunogenicity and Reactogenicity of a Pneumococcal Conjugate Vaccine in Healthy Adults
NCT00197821 ·Status: COMPLETED ·Phase: PHASE2
-
Pneumococcal Adult-dose Ranging Immunization Study
NCT00169234 ·Status: COMPLETED ·Phase: PHASE1/PHASE2
-
PPV: Pneumococcal Polysaccharide Vaccine in Older Adults
NCT00239694 ·Status: COMPLETED ·Phase: PHASE4
-
Vaccination Coverage and Level of Protection in Patients at Risk
NCT03820752 ·Status: COMPLETED
-
A Phase 1, Randomized, Controlled, Observer-blinded Trial to Evaluate the Safety and Immunogenicity of a Multivalent Pneumococcal Conjugate Vaccine in Healthy Adults Aged 18 to 49 Years
NCT02955160 ·Status: COMPLETED ·Phase: PHASE1
-
Identifocation the B Cell Subsets Responsible for Anti-pneumococcal Response
NCT02126384 ·Status: COMPLETED ·Phase: NA
-
Safety and Immunogenicity Study of 23-valent Pneumococcal Polysaccharide Vaccine in Healthy Children, Adults and Elderly
NCT02451969 ·Status: COMPLETED ·Phase: PHASE3
-
Revaccination With PPS23 Boosted or Not by PCV13 in Splenectomised Patients.
NCT03873727 ·Status: UNKNOWN ·Phase: PHASE2
-
Immune Memory Evaluation in Children Following a Primary Vaccination With Pneumococcal Conjugate Vaccines.
NCT00333450 ·Status: COMPLETED ·Phase: PHASE3
-
Study Evaluating Prevnar Infant Long-term Immune Response Versus Prevnar Naive Cohort
NCT00824850 ·Status: COMPLETED ·Phase: PHASE2
-
Trial to Evaluate the Safety and Immunogenicity of a Multivalent Pneumococcal Vaccine in Healthy Infants
NCT03512288 ·Status: COMPLETED ·Phase: PHASE2
-
Residual Anti-pneumococcal Immunity After Pneumococcal Immunization in ANCA-associated Vasculitis
NCT02463539 ·Status: COMPLETED
-
Study Evaluating A 13-Valent Pneumococcal Conjugate Vaccine Administered To Infants In Korea
NCT00689351 ·Status: COMPLETED ·Phase: PHASE2
-
Evaluation of the Post-vaccination Immune Response to COVID-19 in the New Caledonian Population
NCT05135585 ·Status: COMPLETED ·Phase: NA
-
Multicenter Pilot Study Evaluating the Immunogenicity of an Innovative Pneumococcal Vaccination Strategy in Splenectomized Adults
NCT02052154 ·Status: COMPLETED ·Phase: PHASE2
-
Clinical Study on Lot-to-lot Consistency and Immune Persistence of Three Commercial Batches of PPSV23
NCT06314867 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE3
-
Safety, Tolerability, and Immunogenicity of VAX-31 in Adults ≥50 Years With Immunobridging to Adults 18-49
NCT07284654 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE3
-
A Study to Evaluate the Safety, Tolerability and Immunogenicity of V114 in Healthy Adults and Infants (V114-005)
NCT02531373 ·Status: COMPLETED ·Phase: PHASE1/PHASE2